Skip to main content
Explore URMC

UR Medicine

menu

Secondary Prevention: General Antithrombotic Therapy

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE)

Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial

Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events

Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial

Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial

European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent Stroke

A Randomized Trial of Anticoagulants Versus Aspirin after Cerebral Ischemia of Presumed Arterial Origin

A Comparison of Wafarin and Aspirin for the Prevention of Recurrent Ischemic Stroke